NIH-funded research R01 grant

The effect of social isolation on aging health in people with schizophrenia

Official title: The impact of social isolation on aging health in schizophrenia

Funded at Icahn School of Medicine at Mount Sinai · NIH-11551514 · Data updated 2026-11-12

This study explores how being socially isolated may speed up aging-related health problems in people with schizophrenia.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 15, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$3,398
NIH project number3R01MH128971-05S1
Project IDNIH-11551514 on NIH RePORTER

Who could benefit from this research

Could help

Individuals diagnosed with schizophrenia or related disorders who have aging-related health concerns and live in or near participating sites in the US or Europe.

Less likely to help

Participants without significant social isolation or with atypical aging health trajectories may see limited direct benefit.

What this research studies

People with schizophrenia often face early health problems and a shorter life expectancy. This project will combine data from the US and Europe to see if limited social contact accelerates aging-related conditions. Researchers will use deep phenotypic information and long-term follow-up to examine links between social isolation and health across aging. The goal is to understand how social factors interact with brain disorders to influence physical health as people get older.

Why it matters

Potential benefit: If successful, findings could inform interventions to reduce social isolation and improve aging-related health in schizophrenia.

How similar studies have gone: Prior research shows social factors affect physical health in aging populations, but this project tests these links specifically in schizophrenia across international cohorts.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Reichenberg, Abraham — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Reichenberg, Abraham

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.